Comparative transcriptome profiling in human bicuspid aortic valve disease using RNA sequencing

Physiological Genomics

Volumn 47, Issue 3, 2015, Pages 75-87

  Padang, Ratnasari ^a,b,c,d   Bagnall, Richard D ^a,b   Tsoutsman, Tatiana ^a,b   Bannon, Paul G ^b,c,d   Semsarian, Christopher ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d The Baird Institute   (Australia)

Author keywords

Bicuspid aortic valve; Calcification; RNA sequencing; Transcriptome

Indexed keywords

ADAMTS9 PROTEIN; AGGRECAN; NOTCH1 RECEPTOR; PROTEIN; SEMA6B PROTEIN; SEMAPHORIN 3F; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA VALVE; ARTICLE; BICUSPID AORTIC VALVE; CLINICAL ARTICLE; COMPARATIVE STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRICUSPID AORTIC VALVE; TRICUSPID VALVE; UPREGULATION; VALIDATION STUDY; COHORT ANALYSIS; CONGENITAL MALFORMATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SEQUENCE ANALYSIS; VALVULAR HEART DISEASE;

TOMATO ASPERMY VIRUS;

AGED; AORTIC VALVE; COHORT STUDIES; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, RNA; UP-REGULATION;

EID: 84923915598     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00115.2014     Document Type: Article

References (33)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, 2006 Writing Committee Members, American College of Cardiology/American Heart Association Task Force.2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation118: e523–e661, 2008.
2. Borzi RM, Olivotto E, Pagani S, Vitellozzi R, Neri S, Battistelli M, Falcieri E, Facchini A, Flamigni F, Penzo M, Platano D, Santi S, Facchini A, Marcu KB.Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors.Arthritis Rheum62: 2370–2381, 2010.
3. Bosse Y, Miqdad A, Fournier D, Pepin A, Pibarot P, Mathieu P.Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.Circ Cardiovasc Genet2: 489–498, 2009.
4. Brien P, Pugazhendhi D, Woodhouse S, Oxley D, Pell JM. p38α MAPK regulates adult muscle stem cell fate by restricting progenitor proliferation during postnatal growth and repair. Stem Cells31: 1597–1610, 2013.
5. Cheek JD, Wirrig EE, Alfieri CM, James JF, Yutzey KE. Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease.J Mol Cell Cardiol52: 689–700, 2012.
6. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable.J Am Coll Cardiol44: 138–143, 2004.
7. Ducharme V, Guauque-Olarte S, Gaudreault N, Pibarot P, Mathieu P, Bosse Y. NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis.J Heart Valve Dis 22: 142–149, 2013.
8. Edep ME, Shirani J, Wolf P, Brown DL. Matrix metalloproteinase expression in nonrheumatic aortic stenosis.Cardiovasc Pathol9: 281–286, 2000.
9. Engin F, Yao Z, Yang T, Zhou G, Bertin T, Jiang MM, Chen Y, Wang L, Zheng H, Sutton RE, Boyce BF, Lee B. Dimorphic effects of Notch signaling in bone homeostasis.Nat Med14: 299–305, 2008.
10. Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, Couetil JP, Henin D, Michel JB, Vahanian A, Jacob MP. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.Eur Heart J26: 1333–1341, 2005.
11. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease.Nature437: 270–274, 2005.
12. Hinton RB, Martin LJ, Rame-Gowda S, Tabangin ME, Cripe LH, Benson DW. Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve.J Am Coll Cardiol53: 1065–1071, 2009.
13. Kamath AR, Pai RG. Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.Int J Angiol17: 63–70, 2008.
14. Kern CB, Wessels A, McGarity J, Dixon LJ, Alston E, Argraves WS, Geeting D, Nelson CM, Menick DR, Apte SS. Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.Matrix Biol29: 304–316, 2010.
15. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.Genome Biol14: R36, 2013.
16. Kogenaru S, Qing Y, Guo Y, Wang N. RNA-seq and microarray complement each other in transcriptome profiling.BMC Genomics13: 629, 2012.
17. Koullias GJ, Korkolis DP, Ravichandran P, Psyrri A, Hatzaras I, Elefteriades JA. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.Eur J Cardiothorac Surg26: 1098–1103, 2004.
18. Lincoln J, Lange AW, Yutzey KE. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development.Dev Biol294: 292–302, 2006.
19. McKellar SH, Michelena HI, Li Z, Schaff HV, Sundt TM 3rd. Long-term risk of aortic events following aortic valve replacement in patients with bicuspid aortic valves.Am J Cardiol106: 1626–1633, 2010.
20. Michelena HI, Desjardins VA, Avierinos JF, Russo A, Nkomo VT, Sundt TM, Pellikka PA, Tajik AJ, Enriquez-Sarano M. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community.Circulation117: 2776–2784, 2008.
21. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, Edwards WD, Sundt TM 3rd, Enriquez-Sarano M. Incidence of aortic complications in patients with bicuspid aortic valves.JAMA306: 1104–1112, 2011.
22. Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis.J Thorac Cardiovasc Surg142: 895–901, 2011.
23. Nagy E, Andersson DC, Caidahl K, Eriksson MJ, Eriksson P, Franco-Cereceda A, Hansson GK, Back M. Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts.Circulation123: 1316–1325, 2011.
24. Nigam V, Sievers HH, Jensen BC, Sier HA, Simpson PC, Srivastava D, Mohamed SA.Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves.J Heart Valve Dis19: 459–465, 2010.
25. Padang R, Bagnall RD, Richmond DR, Bannon PG, Semsarian C.Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease.J Mol Cell Cardiol53: 277–281, 2012.
26. Padang R, Bagnall RD, Semsarian C.Genetic basis of familial valvular heart disease.Circ Cardiovasc Genet5: 569–580, 2012.
27. Park SK, Prolla TA.Gene expression profiling studies of aging in cardiac and skeletal muscles.Cardiovasc Res66: 205–212, 2005.
28. Ricci M, Xu Y, Hammond HL, Willoughby DA, Nathanson L, Rodriguez MM, Vatta M, Lipshultz SE, Lincoln J.Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome.PLoS One7: e29784, 2012.
29. Rusanescu G, Weissleder R, Aikawa E.Notch signaling in cardiovascular disease and calcification.Curr Cardiol Rev4: 148–156, 2008.
30. Siu SC, Silversides CK.Bicuspid aortic valve disease.J Am Coll Cardiol55: 2789–2800, 2010.
31. Tutar E, Ekici F, Atalay S, Nacar N.The prevalence of bicuspid aortic valve in newborns by echocardiographic screening.Am Heart J150: 513–515, 2005.
32. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT, Webb GD, Siu SC.Outcomes in adults with bicuspid aortic valves.JAMA300: 1317–1325, 2008.
33. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F.Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.Genome Biol3: RESEARCH0034, 2002.